News Highlights

Thai vaccine to enter third phase of trials
Thai vaccine to enter third phase of trials

Chulalongkorn University’s Centre of Excellence in Vaccine Research and Development expects to register its mRNA Covid-19 vaccine, known as ChulaCOV-19, mid-next year. Trial results are expected for analysis during April-May 2022.

The World Health Organization Living Guidelines
The World Health Organization Living Guidelines

Contains the organization’s most up-to-date recommendations on drugs to prevent COVID-19, Therapeutics and Clinical management of COVID19. It is updated regularly as new evidence emerges.

COVID-19 Vaccines for Immunocompromised People
COVID-19 Vaccines for Immunocompromised People

People with moderately to severely compromised immune systems are especially vulnerable to COVID-19. An additional dose intended to improve immunocompromised people’s response to their initial vaccine series.